NCT00096525View on ClinicalTrials.gov

Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2004

Primary Completion Date

August 31, 2005

Conditions
Kidney Cancer
Interventions
DRUG

lenalidomide

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00096525 - Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer | Biotech Hunter | Biotech Hunter